MENU
+Compare
ALBHF
Stock ticker: OTC
AS OF
Oct 17 closing price
Price
$0.79
Change
+$0.03 (+3.95%)
Capitalization
12.25B

ALBHF stock forecast, quote, news & analysis

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on... Show more

ALBHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for ALBHF with price predictions
Oct 17, 2025

ALBHF in -9.60% downward trend, declining for three consecutive days on September 26, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ALBHF declined for three days, in of 175 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALBHF as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALBHF turned negative on September 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

ALBHF moved below its 50-day moving average on October 14, 2025 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALBHF's RSI Indicator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where ALBHF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

ALBHF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 141 cases where ALBHF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALBHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.525) is normal, around the industry mean (5.536). P/E Ratio (63.053) is within average values for comparable stocks, (45.786). Projected Growth (PEG Ratio) (1.253) is also within normal values, averaging (1.504). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. P/S Ratio (2.952) is also within normal values, averaging (11.793).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALBHF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 3.6B. The market cap for tickers in the group ranges from 3.29K to 25.03B. JDHIF holds the highest valuation in this group at 25.03B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was -2%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 9%. RDGT experienced the highest price growth at 18%, while HEWA experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was 121%. For the same stocks of the Industry, the average monthly volume growth was 22% and the average quarterly volume growth was 386%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 72
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 95
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
ALBHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry DrugstoreChains

Profile
Fundamentals
Details
Industry
N/A
Address
Guanghua Road
Phone
N/A
Employees
1560
Web
https://www.alihealth.cn